loadpatents
Patent applications and USPTO patent grants for Klaus; Christine.The latest application filed is for "aryl-or heteroaryl-substituted benzene compounds".
Patent | Date |
---|---|
6'-sialyllactose for use in the treatment of hearing loss Grant 11,291,675 - Neumann , et al. April 5, 2 | 2022-04-05 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20210379076 - KUNTZ; Kevin W. ;   et al. | 2021-12-09 |
Aryl-or heteroaryl-substituted benzene compounds Grant 11,052,093 - Kuntz , et al. July 6, 2 | 2021-07-06 |
Combination Therapy For Treating Cancer App 20210100810 - KLAUS; Christine ;   et al. | 2021-04-08 |
6'-sialyllactose For Use In The Treatment Of Hearing Loss App 20200289537 - NEUMANN; Harald ;   et al. | 2020-09-17 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20200155562 - KUNTZ; Kevin W. ;   et al. | 2020-05-21 |
Methods Of Using Ehmt2 Inhibitors App 20200113901 - CAMPBELL; John Emmerson ;   et al. | 2020-04-16 |
Combination Therapies With Ehmt2 Inhibitors App 20200054635 - CAMPBELL; John Emmerson ;   et al. | 2020-02-20 |
Combination Therapy For Treating Cancer App 20200030355 - KLAUS; Christine ;   et al. | 2020-01-30 |
Combination therapy for treating cancer Grant 10,525,074 - Klaus , et al. J | 2020-01-07 |
Aryl-or heteroaryl-substituted benzene compounds Grant 10,420,775 - Kuntz , et al. Sept | 2019-09-24 |
Combination Therapy For Treating Cancer App 20190083521 - Klaus; Christine ;   et al. | 2019-03-21 |
Aryl- or heteroaryl-substituted benzene compounds Grant 10,155,002 - Kuntz , et al. Dec | 2018-12-18 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20180318309 - KUNTZ; Kevin W. ;   et al. | 2018-11-08 |
Combination Therapy For Treating Cancer App 20180028552 - Klaus; Christine ;   et al. | 2018-02-01 |
Aryl-or heteroaryl-substituted benzene compounds Grant 9,855,275 - Kuntz , et al. January 2, 2 | 2018-01-02 |
Aryl-or Heteroaryl-substituted Benzene Compounds App 20170252349 - KUNTZ; Kevin W. ;   et al. | 2017-09-07 |
Combination Therapy For Treating Cancer App 20170232030 - Klaus; Christine ;   et al. | 2017-08-17 |
Aryl- Or Heteroaryl-substituted Benzene Compounds App 20170119780 - Kuntz; Kevin Wayne ;   et al. | 2017-05-04 |
Combination Therapy For Treating Cancer App 20170080010 - Klaus; Christine ;   et al. | 2017-03-23 |
Aryl- or heteroaryl-substituted benzene compounds Grant 9,549,931 - Kuntz , et al. January 24, 2 | 2017-01-24 |
Aryl- or heteroaryl-substituted benzene compounds Grant 9,522,152 - Kuntz , et al. December 20, 2 | 2016-12-20 |
Substituted Benzene Compounds App 20160332969 - Kuntz; Kevin W. ;   et al. | 2016-11-17 |
Combination therapy for treating cancer Grant 9,446,064 - Klaus , et al. September 20, 2 | 2016-09-20 |
Dihidropyridin-2-one benzamine compounds Grant 9,376,422 - Kuntz , et al. June 28, 2 | 2016-06-28 |
Combination Therapy For Treating Cancer App 20160045531 - Klaus; Christine ;   et al. | 2016-02-18 |
Aryl- Or Heteroaryl-substituted Benzene Compounds App 20160022693 - Kuntz; Kevin Wayne ;   et al. | 2016-01-28 |
Aryl- Or Heteroaryl-substituted Benzene Compounds App 20150353494 - Kuntz; Kevin Wayne ;   et al. | 2015-12-10 |
Aryl- or heteroaryl-substituted benzene compounds Grant 9,090,562 - Kuntz , et al. July 28, 2 | 2015-07-28 |
Combination Therapy for Treating Cancer App 20140323421 - Klaus; Christine ;   et al. | 2014-10-30 |
Aryl- or Heteroaryl-Substituted Benzene Compounds App 20140288041 - Kuntz; Kevin Wayne ;   et al. | 2014-09-25 |
Aryl- or heteroaryl-substituted benzene compounds Grant 8,765,732 - Kuntz , et al. July 1, 2 | 2014-07-01 |
Substituted Benzene Compounds App 20140142083 - Kuntz; Kevin Wayne ;   et al. | 2014-05-22 |
Aryl- or Heteroaryl-Substituted Benzene Compounds App 20130123234 - Kuntz; Kevin Wayne ;   et al. | 2013-05-16 |
Aryl- or Heteroaryl-Substituted Benzene Compounds App 20120264734 - KUNTZ; KEVIN W. ;   et al. | 2012-10-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.